Imris Stock Price, News & Analysis (OTCMKTS:IMRSQ)

$0.0035 0.00 (0.00 %)
(As of 12/12/2017 10:44 AM ET)
Previous Close$0.00
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average Volume9,123 shs
Market Capitalization$219,100.00
P/E RatioN/A
Dividend YieldN/A
Beta-1.71

About Imris (OTCMKTS:IMRSQ)

Imris logoImaging Canada Liquidating Corp, formerly IMRIS Inc (IMRIS), is a Canada-based company, which designs, manufactures and markets the VISIUS Surgical Theatre, a multifunctional surgical environment that provides intraoperative vision to clinicians to assist in decision-making and precision in treatment. It can incorporate magnetic resonance (MR) imaging, computed tomography (CT) imaging and x-ray angiography in various configurations. IMRIS sells the VISIUS Surgical Theatres to hospitals that deliver clinical services to patients in the neurosurgical, spinal, cerebrovascular and cardiovascular markets. Its VISIUS iMRI provides imaging using Siemens 1.5T (tesla) and 3T MR core technology to enable imaging capabilities, including spectroscopy, fMRI and DTI. Its SYMBIS Surgical System is an MR and CT-compatible image guided surgical robot. Its VISIUS iCT is a multifunctional surgical theater that brings CT image quality with low dose management directly to patients in the operating room.

Receive IMRSQ News and Ratings via Email

Sign-up to receive the latest news and ratings for IMRSQ and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:IMRSQ
CUSIPN/A
Phone+1-204-4807090

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$28.89 million
Price / Sales0.01
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares62,590,000

Imris (OTCMKTS:IMRSQ) Frequently Asked Questions

What is Imris' stock symbol?

Imris trades on the OTCMKTS under the ticker symbol "IMRSQ."

How were Imris' earnings last quarter?

Imris Inc. (OTCMKTS:IMRSQ) released its earnings results on Tuesday, October, 28th. The company reported ($0.16) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.10) by $0.06. The company earned $6.90 million during the quarter, compared to the consensus estimate of $8.07 million. View Imris' Earnings History.

Who are some of Imris' key competitors?

Who are Imris' key executives?

Imris' management team includes the folowing people:

  • H. David Graves, Chairman of the Board
  • Jay D. Miller, President, Chief Executive Officer, Chief Operating Officer
  • Meir Dahan, Executive Vice President - Research and Development, Chief Technology Officer
  • R. Stephen Armstrong, Independent Director (Age 64)
  • Carey Diamond, Independent Director
  • William C. Fraser, Independent Director
  • James B. Hickey Jr., Independent Director (Age 58)
  • Blaine Hobson, Independent Director

How do I buy Imris stock?

Shares of Imris can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Imris' stock price today?

One share of Imris stock can currently be purchased for approximately $0.00.

How big of a company is Imris?

Imris has a market capitalization of $219,100.00 and generates $28.89 million in revenue each year.

How can I contact Imris?

Imris' mailing address is 100-1370 Sony Pl, WINNIPEG, MB R3T 1N5, Canada. The company can be reached via phone at +1-204-4807090 or via email at [email protected]


MarketBeat Community Rating for Imris (IMRSQ)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  78 (Vote Outperform)
Underperform Votes:  46 (Vote Underperform)
Total Votes:  124
MarketBeat's community ratings are surveys of what our community members think about Imris and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Imris (OTCMKTS:IMRSQ) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Imris (OTCMKTS:IMRSQ) Earnings History and Estimates Chart

Earnings by Quarter for Imris (OTCMKTS:IMRSQ)

Imris (OTCMKTS IMRSQ) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/4/2015Q414($0.07)($0.13)$13.10 million$9.60 millionViewN/AView Earnings Details
10/28/2014Q314($0.10)($0.16)$8.07 million$6.90 millionViewN/AView Earnings Details
8/7/2014($0.14)ViewN/AView Earnings Details
5/13/2014Q114($0.10)($0.15)$8.83 million$8.15 millionViewN/AView Earnings Details
3/4/2014Q4 13($0.20)($0.42)ViewN/AView Earnings Details
8/13/2013Q213($0.16)($0.16)$10.12 million$10.23 millionViewN/AView Earnings Details
11/8/2012Q312($0.14)($0.19)$12.72 million$11.57 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Imris (OTCMKTS:IMRSQ) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Imris (OTCMKTS:IMRSQ)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Imris (OTCMKTS IMRSQ)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Imris (OTCMKTS IMRSQ) News Headlines

Source:
No headlines for this company have been tracked by MarketBeat.com

SEC Filings

Imris (OTCMKTS:IMRSQ) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Imris (OTCMKTS IMRSQ) Stock Chart for Tuesday, December, 12, 2017

Loading chart…

This page was last updated on 12/12/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.